Nektar Therapeutics
F:ITH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nektar Therapeutics
F:ITH
|
US |
|
N
|
Nektar Therapeutics
XMUN:ITH
|
US |
|
B
|
B&G Foods Inc
XMUN:DHR
|
US |
Wall St Price Targets
ITH Price Targets Summary
Nektar Therapeutics
According to Wall Street analysts, the average 1-year price target for ITH is 42 EUR with a low forecast of 21.72 EUR and a high forecast of 54.18 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ITH's stock price target?
Price Target
42
EUR
According to Wall Street analysts, the average 1-year price target for ITH is 42 EUR with a low forecast of 21.72 EUR and a high forecast of 54.18 EUR.
What is the Revenue forecast for Nektar Therapeutics?
Projected CAGR
48%
Over the last 13 years, the compound annual growth rate for Revenue has been -3%. The projected CAGR for the next 8 years is 48%.
What is the Gross Profit forecast for Nektar Therapeutics?
Projected CAGR
47%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 8 years is 47%.
